| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research
|
Basset-Sagarminaga, Jeremy
|
|
|
67 |
3 |
p. 407-419
|
artikel
|
| 2 |
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
|
Krishnan, Arunkumar
|
|
|
67 |
3 |
p. 483-493
|
artikel
|
| 3 |
Comments on the notion of false positivity in measurements of autoantibodies
|
Grill, Valdemar
|
|
|
67 |
3 |
p. 567-568
|
artikel
|
| 4 |
Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]
|
Thomas, Nicholas J.
|
|
|
67 |
3 |
p. 569-570
|
artikel
|
| 5 |
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
|
Blüher, Matthias
|
|
|
67 |
3 |
p. 470-482
|
artikel
|
| 6 |
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
|
Gandasi, Nikhil R.
|
|
|
67 |
3 |
p. 528-546
|
artikel
|
| 7 |
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy
|
Dhanapalaratnam, Roshan
|
|
|
67 |
3 |
p. 561-566
|
artikel
|
| 8 |
Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study
|
Gregg, Edward W.
|
|
|
67 |
3 |
p. 459-469
|
artikel
|
| 9 |
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018
|
Regnault, Nolwenn
|
|
|
67 |
3 |
p. 516-527
|
artikel
|
| 10 |
MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial
|
Heianza, Yoriko
|
|
|
67 |
3 |
p. 506-515
|
artikel
|
| 11 |
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function
|
Baumel-Alterzon, Sharon
|
|
|
67 |
3 |
p. 547-560
|
artikel
|
| 12 |
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study
|
Raubenheimer, Peter J.
|
|
|
67 |
3 |
p. 494-505
|
artikel
|
| 13 |
The impact of taxing sugar-sweetened beverages on diabetes: a critical review
|
Peñalvo, José L.
|
|
|
67 |
3 |
p. 420-429
|
artikel
|
| 14 |
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review
|
Ahmed, Rabeeyah
|
|
|
67 |
3 |
p. 443-458
|
artikel
|
| 15 |
Type 2 diabetes and succinate: unmasking an age-old molecule
|
Fernández-Veledo, Sonia
|
|
|
67 |
3 |
p. 430-442
|
artikel
|
| 16 |
Up Front
|
|
|
|
67 |
3 |
p. 405-406
|
artikel
|
Tijdschrift beschrijving